Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Virax Biolabs Group Ltd. Class A (VRAX)
NASDAQ:VRAX
Holding VRAX?
Track your performance easily
VRAX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.60 - $9.00
Previous CloseN/A
Volume267.06K
Average Volume (3M)532.12K
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$22.61K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.11
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.37
Shares Outstanding4,341,956
10 Day Avg. Volume201,379
30 Day Avg. Volume532,120
Standard Deviation0.60
R-Squared0.02
Alpha-0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)59.10
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Virax Biolabs Group Ltd. Class A News
PremiumCompany Announcements
Virax Biolabs Achieves Shareholder Approvals at Adjourned Annual MeetingPremiumCompany Announcements
Virax Biolabs Announces Strategic Goals and Developments for 2025
PremiumCompany Announcements
Virax Biolabs Expands ImmuneSelect Reach in Europe
PremiumCompany Announcements
Virax Biolabs Sees Asset Growth Amid Financial Loss
PremiumCompany Announcements
Virax Biolabs Sets Date for 2024 AGMPremiumCompany Announcements
Virax Biolabs Expands Reach with Europa Biosite DealOwnership Overview
―
Insiders
0.01%
Mutual Funds
<0.01% Other Institutional Investors
99.98% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
VRAX FAQ
What was Virax Biolabs Group Ltd. Class A’s price range in the past 12 months?
Virax Biolabs Group Ltd. Class A lowest stock price was $0.60 and its highest was $9.00 in the past 12 months.
What is Virax Biolabs Group Ltd. Class A’s market cap?
Currently, no data Available
When is Virax Biolabs Group Ltd. Class A’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Virax Biolabs Group Ltd. Class A’s earnings last quarter?
Virax Biolabs Group Ltd. Class A released its earnings results on Feb 02, 2023. The company reported -$1.238 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.238.
Is Virax Biolabs Group Ltd. Class A overvalued?
According to Wall Street analysts Virax Biolabs Group Ltd. Class A’s price is currently Overvalued.
Does Virax Biolabs Group Ltd. Class A pay dividends?
Virax Biolabs Group Ltd. Class A does not currently pay dividends.
What is Virax Biolabs Group Ltd. Class A’s EPS estimate?
Virax Biolabs Group Ltd. Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Virax Biolabs Group Ltd. Class A have?
Virax Biolabs Group Ltd. Class A has 4,341,956 shares outstanding.
What happened to Virax Biolabs Group Ltd. Class A’s price movement after its last earnings report?
Virax Biolabs Group Ltd. Class A reported an EPS of -$1.238 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 6.892%.
Which hedge fund is a major shareholder of Virax Biolabs Group Ltd. Class A?
Currently, no hedge funds are holding shares in VRAX
---
Company Description
Virax Biolabs Group Ltd. Class A
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of immunology.
---
Technical Analysis
Alpha Pro Tech
―
Trinity Biotech
―
Dyadic International
―
Co-Diagnostics
―
Inhibrx Biosciences Inc
―
---